Latest Board Appointments News

Wingara Limited has entered an exclusive agreement with Terra Firma Limited to explore and acquire meat industry businesses, securing $750,000 in initial funding. Trading on the ASX is suspended pending re-compliance and relisting.

AUCyber Limited has announced a significant reshuffle of its leadership team, appointing Chris Wright as CEO and welcoming three new non-executive directors, signaling a strategic pivot for the cyber security firm.

Bell Financial Group reported a robust 26.4% increase in profit after tax to $30.7 million for 2024, underpinned by strong performances across all divisions and a declared fully franked final dividend of 4.0 cents per share. The Group is actively pursuing growth through acquisitions and strategic account transfers, positioning itself for a cautiously optimistic 2025.

Noble Helium Limited has announced a sweeping board and executive reshuffle following pressure from major shareholders, signaling a strategic reset aimed at strengthening its financial footing and advancing its Tanzanian helium projects.

Sun Silver has appointed co-founder Andrew Dornan as Managing Director and corporate lawyer Shaun Hardcastle as Non-Executive Chairman, signaling a strategic push to advance its flagship Maverick Springs Silver-Gold Project in Nevada.

Trigg Minerals has secured NSW Government approval for the transfer of its Achilles Project licence, enabling formal exploration of the high-grade Wild Cattle Creek antimony deposit.

Charter Hall Retail REIT reports solid 1H FY25 results with $73.1 million operating earnings and strategic moves to enhance income growth, including a major stake in Hotel Property Investments Ltd.

DMC Mining Limited progresses its strategic acquisition of the Firawa and Labé uranium projects in Guinea, while navigating key board appointments and capital raising efforts ahead of ASX re-admission.

Investor Centre Limited’s December quarter report reveals a strategic pivot with the withdrawal of its capital raising prospectus, the appointment of a new director, and ongoing talks to expand its wholesale financial services.

Cambium Bio has secured a A$3 million capital raise and achieved FDA Fast Track status for its lead ophthalmology product, Elate Ocular®, setting the stage for Phase 3 trials in mid-2025.

Voltaic Strategic Resources reports significant gold and poly-metallic mineralisation at its Kooline and Meekatharra projects, alongside a strategic board restructure and a robust cash position of $5.4 million.

Lykos Metals Limited reports significant high-grade mineral findings at its Sinjakovo Project and extends its Jezero exploration permit, alongside key board appointments and cost restructuring.